Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,036.00 JPY | +0.42% |
|
+0.22% | -1.20% |
Jul. 11 | Hisamitsu Buys Back 7.11 Billion Yen Worth of Shares for 7.11 Billion Yen via ToSTNeT-3 | MT |
Jul. 10 | Hisamitsu Pharmaceutical Co., Inc. authorizes a Buyback Plan. | CI |
Business description: Hisamitsu Pharmaceutical Co., Inc.
Number of employees: 2,799
Sales by Activity: Hisamitsu Pharmaceutical Co., Inc.
Fiscal Period: February | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Medicine and Related Product Business | - | - | - | - | 153B |
Others | 2.75B | 2.9B | 3.13B | 3.25B | 3.35B |
Pharmaceuticals Business | 112B | 117B | 125B | 138B | - |
Geographical breakdown of sales: Hisamitsu Pharmaceutical Co., Inc.
Fiscal Period: February | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Japan | 75.17B | 78.73B | 74.64B | 81.03B | 82.36B |
United States of America | 22.26B | 22.1B | 28.3B | 31.04B | 38.9B |
Others | 17.08B | 19.36B | 25.4B | 29.64B | 34.75B |
Executive Committee: Hisamitsu Pharmaceutical Co., Inc.
Manager | Title | Age | Since |
---|---|---|---|
President | 53 | 2015-04-30 | |
Takaaki Terahara
CTO | Chief Tech/Sci/R&D Officer | - | - |
Naruhito Higo
CTO | Chief Tech/Sci/R&D Officer | 62 | - |
Nobuo Tsutsumi
CMP | Compliance Officer | 61 | 2014-04-30 |
Koji Takiyama
PRN | Corporate Officer/Principal | 53 | 2017-04-30 |
Composition of the Board of Directors: Hisamitsu Pharmaceutical Co., Inc.
Director | Title | Age | Since |
---|---|---|---|
Midori Noguchi
BRD | Director/Board Member | 68 | 2025-05-21 |
Director/Board Member | 53 | 2007-04-30 | |
Kousuke Sugiyama
BRD | Director/Board Member | 73 | 1999-04-30 |
Koji Takiyama
BRD | Director/Board Member | 53 | 2022-04-30 |
Yuichiro Anzai
BRD | Director/Board Member | 78 | 2020-04-30 |
Tetsugo Matsuo
BRD | Director/Board Member | - | 2020-04-30 |
Kyu Saito
BRD | Director/Board Member | 62 | 2013-04-30 |
Nobuo Tsutsumi
BRD | Director/Board Member | 61 | 2014-04-30 |
Director/Board Member | 57 | 2014-04-30 |
Holdings: Hisamitsu Pharmaceutical Co., Inc.
Name | Equities | % | Valuation |
---|---|---|---|
1,762,525 | 2.34% | 50,077,213 $ | |
1,151,000 | 0.24% | 44,360,254 $ | |
TOPPAN HOLDINGS INC. 0.38% | 1,209,841 | 0.38% | 32,874,973 $ |
SHIMANO INC. 0.17% | 154,400 | 0.17% | 22,345,752 $ |
SEIREN CO.,LTD. 1.69% | 1,090,000 | 1.69% | 17,567,377 $ |
1,583,500 | 0.32% | 17,090,779 $ | |
OSAKA SODA CO., LTD. 0.98% | 1,305,000 | 0.98% | 16,235,140 $ |
716,700 | 0.24% | 14,862,925 $ | |
MIURA CO., LTD. 0.58% | 721,500 | 0.58% | 14,500,433 $ |
KURARAY CO., LTD. 0.33% | 1,067,000 | 0.33% | 13,554,955 $ |
Company details: Hisamitsu Pharmaceutical Co., Inc.
Hisamitsu Pharmaceutical Co., Inc.
408 Tashiro Daikan-machi
841-0017, Tosu
+81 3 5293 1720
http://www.hisamitsu.co.jp
Other Pharmaceuticals
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
+0.42% | +0.22% | +0.87% | +17.50% | 1.93B | ||
+1.34% | -2.40% | -14.78% | +132.72% | 684B | ||
+0.44% | +3.81% | +4.55% | -8.15% | 392B | ||
-1.12% | -2.94% | +7.98% | +23.20% | 338B | ||
-2.22% | -8.99% | -54.89% | -0.94% | 292B | ||
+0.58% | -1.71% | -5.66% | -22.10% | 256B | ||
-1.12% | -6.98% | -6.83% | +11.70% | 225B | ||
-0.17% | -3.12% | -15.93% | -7.34% | 214B | ||
-1.91% | -4.83% | -36.48% | -15.80% | 205B | ||
-1.17% | -1.87% | -12.19% | +18.53% | 160B | ||
Average | -0.42% | -2.21% | -13.34% | +14.93% | 276.83B | |
Weighted average by Cap. | -0.41% | -2.28% | -13.54% | +32.61% |
Sector

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 4530 Stock
- Company Hisamitsu Pharmaceutical Co., Inc.
Select your edition
All financial news and data tailored to specific country editions